PDB11 CLINICAL AND COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 ONCE OR TWICE DAILY VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES MELLITUS- A MODELING ANALYSIS IN THE CHINESE SETTING
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73186-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)73186-2/fulltext
Title :
PDB11 CLINICAL AND COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 ONCE OR TWICE DAILY VERSUS INSULIN GLARGINE IN TYPE 2 DIABETES MELLITUS- A MODELING ANALYSIS IN THE CHINESE SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73186-2&doi=10.1016/S1098-3015(11)73186-2
First page :
A528
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1346